For patients requiring short-term anticoagulation after surgical aortic or mitral valve procedures, edoxaban (Savaysa; Daiichi Sankyo) is noninferior to warfarin for preventing thromboembolism and ...
Hematoma volume predicts outcome and mortality risk following intracerebral hemorrhage (ICH). Therapies that decrease coagulability could cause enlargement of hematomas, thereby increasing the risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results